The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.
Patient-derived xenograft (PDX) models in basic and translational breast cancer research
Open accessAbstract
Patient-derived xenograft (PDX) models of a growing spectrum of cancers are rapidly supplanting long-established traditional cell lines as preferred models for conducting basic and translational preclinical research. In breast cancer, to complement the now curated collection of approximately 45 long-established human breast cancer cell lines, a newly formed consortium of academic laboratories, currently from Europe, Australia, and North America, herein summarizes data on over 500 stably transplantable PDX models representing all three clinical subtypes of breast cancer (ER+, HER2+, and “Triple-negative” (TNBC)). Many of these models are well-characterized with respect to genomic, transcriptomic, and proteomic features, metastatic behavior, and treatment response to a variety of standard-of-care and experimental therapeutics. These stably transplantable PDX lines are generally available for dissemination to laboratories conducting translational research, and contact information for each collection is provided. This review summarizes current experiences related to PDX generation across participating groups, efforts to develop data standards for annotation and dissemination of patient clinical information that does not compromise patient privacy, efforts to develop complementary data standards for annotation of PDX characteristics and biology, and progress toward “credentialing” of PDX models as surrogates to represent individual patients for use in preclinical and co-clinical translational research. In addition, this review highlights important unresolved questions, as well as current limitations, that have hampered more efficient generation of PDX lines and more rapid adoption of PDX use in translational breast cancer research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Genomic signatures to guide the use of chemotherapeutics
Potti, A., Dressman, H. K., Bild, A., Riedel, R. F., Chan, G., Sayer, R., Cragun, J., Cottrill, H., Kelley, M. J., Petersen, R., et al. (2006) · Nature Medicine · doi:10.1038/nm1491 · Cited by 593
RetractedBonnefoi, H., Potti, A., Delorenzi, M., Mauriac, L., Campone, M., Tubiana-Hulin, M., Petit, T., Rouanet, P., Jassem, J., Blot, E., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70345-5 · Cited by 212
Self-citationRetractedAn Integrated Approach to the Prediction of Chemotherapeutic Response in Patients with Breast Cancer
Salter, K. H., Acharya, C. R., Walters, K. S., Redman, R. C., Anguiano, A., Garman, K. S., Anders, C. K., Mukherjee, S., Dressman, H. K., Barry, W. T., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001908 · Cited by 89
RetractedPD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Self-citationMolecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Self-citation(2015) · American Journal Of Pathology · doi:10.2353/ajpath · Cited by 4,908
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S., Voduc, D., Vickery, T., Davies, S., Fauron, C., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,721
Self-citationWolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2775 · Cited by 4,434
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Hammond, M. E. H., Hayes, D. F., Dowsett, M., Allred, D. C., Hagerty, K. L., Badve, S., Fitzgibbons, P. L., Francis, G., Goldstein, N. S., Hayes, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.6529 · Cited by 4,213
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Karnoub, A. E., Dash, A. B., Vo, A. P., Sullivan, A., Brooks, M. W., Bell, G. W., Richardson, A. L., Polyak, K., Tubo, R., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06188 · Cited by 3,206
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188
RAG-1-deficient mice have no mature B and T lymphocytes
Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., & Papaioannou, V. E. (1992) · Cell · doi:10.1016/0092-8674(92)90030-g · Cited by 2,931
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Immune Checkpoint Blockade in Cancer Therapy
Postow, M. A., Callahan, M. K., & Wolchok, J. D. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.4358 · Cited by 2,709
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
Tumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
A severe combined immunodeficiency mutation in the mouse
Bosma, G. C., Custer, R. P., & Bosma, M. J. (1983) · Nature · doi:10.1038/301527a0 · Cited by 2,207
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Prat, A., Parker, J. S., Karginova, O., Fan, C., Livasy, C., Herschkowitz, J. I., He, X., & Perou, C. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2635 · Cited by 2,167
Prognostic and predictive factors in breast cancer by immunohistochemical analysis.
Allred, D. C., Harvey, J. M., Berardo, M. D., & Gm, C. (1998) · PubMed · Cited by 2,143
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Shah, S. P., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., Turashvili, G., Ding, J., Tse, K., Haffari, G., et al. (2012) · Nature · doi:10.1038/nature10933 · Cited by 1,967
Self-citationGenes that mediate breast cancer metastasis to the brain
Bos, P. D., Zhang, X. H.-F., Nadal, C., Shu, W., Gomis, R. R., Nguyen, D. X., Minn, A. J., van de Vijver, M. J., Gerald, W. L., Foekens, J. A., et al. (2009) · Nature · doi:10.1038/nature08021 · Cited by 1,863
Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794
Self-citationWolff, A. C., Hammond, M. E. H., Hicks, D. G., Dowsett, M., McShane, L. M., Allison, K. H., Allred, D. C., Bartlett, J. M. S., Bilous, M., Fitzgibbons, P., et al. (2014) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2013-0953-sa · Cited by 1,762
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Hidalgo, M., Amant, F., Biankin, A. V., Budinská, E., Byrne, A. T., Caldas, C., Clarke, R. B., de Jong, S., Jonkers, J., Mælandsmo, G. M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0001 · Cited by 1,742
Self-citationShultz, L. D., Lyons, B. L., Burzenski, L. M., Gott, B., Chen, X., Chaleff, S., Kotb, M., Gillies, S. D., King, M., Mangada, J., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6477 · Cited by 1,728
Pereira, B., Chin, S.-F., Rueda, O. M., Vollan, H.-K. M., Provenzano, E., Bardwell, H. A., Pugh, M., Jones, L., Russell, R., Sammut, S.-J., et al. (2016) · Nature Communications · doi:10.1038/ncomms11479 · Cited by 1,717
Self-citationDeNardo, D. G., Brennan, D. J., Rexhepaj, E., Ruffell, B., Shiao, S. L., Madden, S. F., Gallagher, W. M., Wadhwani, N., Keil, S. D., Junaid, S. A., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-10-0028 · Cited by 1,715
The landscape of cancer genes and mutational processes in breast cancer
The Oslo Breast Cancer Consortium (OSBREAC), Stephens, P. J., Tarpey, P. S., Davies, H., Van Loo, P., Greenman, C., Wedge, D. C., Nik-Zainal, S., Martin, S., Varela, I., et al. (2012) · Nature · doi:10.1038/nature11017 · Cited by 1,698
Self-citationTumor heterogeneity: Causes and consequences
Marusyk, A., & Polyak, K. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.11.002 · Cited by 1,602
kConFab, Lim, E., Vaillant, F., Wu, D., Forrest, N. C., Pal, B., Hart, A. H., Asselin-Labat, M.-L., Gyorki, D. E., Ward, T., et al. (2009) · Nature Medicine · doi:10.1038/nm.2000 · Cited by 1,492 · cited 1×
“Claudin-low tumors are predominantly TNBC, with comparatively low expression of claudins 3, 4, and 7 [14], enrichment for mesenchymal markers [5], and enrichment of a stem cell-like (CD44/CD24) gene expression signature [5, 15, 16].”
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Mantovani, A., & Sica, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.009 · Cited by 1,484
NOD/SCID/γcnull mouse: an excellent recipient mouse model for engraftment of human cells
Ito, M., Hiramatsu, H., Kobayashi, K., Suzue, K., Kawahata, M., Hioki, K., Ueyama, Y., Koyanagi, Y., Sugamura, K., Tsuji, K., et al. (2002) · Blood · doi:10.1182/blood-2001-12-0207 · Cited by 1,476
The Life History of 21 Breast Cancers
Nik-Zainal, S., Van Loo, P., Wedge, D. C., Alexandrov, L. B., Greenman, C. D., Lau, K. W., Raine, K., Jones, D., Marshall, J., Ramakrishna, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.023 · Cited by 1,443
Self-citationLehmann, B. D., Jovanović, B., Chen, X., Estrada, M. V., Johnson, K. N., Shyr, Y., Moses, H. L., Sanders, M. E., & Pietenpol, J. A. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157368 · Cited by 1,426
Gao, H., Korn, J. M., Ferretti, S., Monahan, J. E., Wang, Y., Singh, M., Zhang, C., Schnell, C., Yang, G., Zhang, Y., et al. (2015) · Nature Medicine · doi:10.1038/nm.3954 · Cited by 1,393
Burstein, M. D., Tsimelzon, A., Poage, G. M., Covington, K. R., Contreras, A., Fuqua, S. A. W., Savage, M. I., Osborne, C. K., Hilsenbeck, S. G., Chang, J. C., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0432 · Cited by 1,392
Molecular Definition of Breast Tumor Heterogeneity
Shipitsin, M., Campbell, L. L., Argani, P., Weremowicz, S., Bloushtain-Qimron, N., Yao, J., Nikolskaya, T., Serebryiskaya, T., Beroukhim, R., Hu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.013 · Cited by 1,353
Deconstructing the molecular portraits of breast cancer
Prat, A., & Perou, C. M. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2010.11.003 · Cited by 1,343
Genomic and transcriptional aberrations linked to breast cancer pathophysiologies
Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W.-L., Lapuk, A., Neve, R. M., Qian, Z., Ryder, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.009 · Cited by 1,317
Herschkowitz, J. I., Simin, K., Weigman, V. J., Mikaelian, I., Usary, J., Hu, Z., Rasmussen, K. E., Jones, L. P., Assefnia, S., Chandrasekharan, S., et al. (2007) · Genome Biology · doi:10.1186/gb-2007-8-5-r76 · Cited by 1,285
Humanized mice in translational biomedical research
Shultz, L. D., Ishikawa, F., & Greiner, D. L. (2007) · Nature Reviews Immunology · doi:10.1038/nri2017 · Cited by 1,279
Transfer of a functional human immune system to mice with severe combined immunodeficiency
Mosier, D. E., Gulizia, R. J., Baird, S. M., & Wilson, D. B. (1988) · Nature · doi:10.1038/335256a0 · Cited by 1,255
Multiple defects in innate and adaptive immunologic function in NOD/LtSz- scid mice.
Shultz, L. D., Schweitzer, P. A., Christianson, S. W., Gott, B., Schweitzer, I. B., Tennent, B., McKenna, S., Mobraaten, L., Rajan, T. V., Greiner, D. L., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.1.180 · Cited by 1,223
Sequence analysis of mutations and translocations across breast cancer subtypes
Banerji, S., Cibulskis, K., Rangel-Escareno, C., Brown, K. K., Carter, S. L., Frederick, A. M., Lawrence, M. S., Sivachenko, A. Y., Sougnez, C., Zou, L., et al. (2012) · Nature · doi:10.1038/nature11154 · Cited by 1,179
Unified nomenclature for the winged helix/forkhead transcription factors
Kaestner, K. H., Knöchel, W., & Martínez, D. E. (2000) · Genes & Development · doi:10.1101/gad.14.2.142 · Cited by 1,158
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Ding, L., Ellis, M. J., Li, S., Larson, D. E., Chen, K., Wallis, J. W., Harris, C. C., McLellan, M. D., Fulton, R. S., Fulton, L. L., et al. (2010) · Nature · doi:10.1038/nature08989 · Cited by 1,139
Self-citationTelli, M. L., Timms, K. M., Reid, J., Hennessy, B., Mills, G. B., Jensen, K. C., Szallasi, Z., Barry, W. T., Winer, E. P., Tung, N. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2477 · Cited by 1,136
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Shah, S. P., Morin, R. D., Khattra, J., Prentice, L., Pugh, T., Burleigh, A., Delaney, A., Gelmon, K., Guliany, R., Senz, J., et al. (2009) · Nature · doi:10.1038/nature08489 · Cited by 1,069
Self-citationDirect Visualization of Macrophage-Assisted Tumor Cell Intravasation in Mammary Tumors
Wyckoff, J. B., Wang, Y., Lin, E. Y., Li, J.-F., Goswami, S., Stanley, E. R., Segall, J. E., Pollard, J. W., & Condeelis, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1823 · Cited by 1,053
Kenny, P. A., Lee, G. Y., Myers, C. A., Neve, R. M., Semeiks, J. R., Spellman, P. T., Lorenz, K., Lee, E. H., Barcellos‐Hoff, M. H., PETERSEN, O. W., et al. (2008) · eScholarship (California Digital Library) · Cited by 1,039
Humanized mice in translational biomedical research
Shultz, L. (2007) · The Mouseion at the JAXlibrary (Jackson Laboratory) · Cited by 1,036
Clonal evolution in breast cancer revealed by single nucleus genome sequencing
Wang, Y., Waters, J., Leung, M. L., Unruh, A., Roh, W., Shi, X., Chen, K., Scheet, P., Vattathil, S., Liang, H., et al. (2014) · Nature · doi:10.1038/nature13600 · Cited by 1,029
Self-citationDeRose, Y. S., Wang, G., Lin, Y.-C., Bernard, P. S., Buys, S. S., Ebbert, M. T. W., Factor, R., Matsen, C., Milash, B. A., Nelson, E., et al. (2011) · Nature Medicine · doi:10.1038/nm.2454 · Cited by 1,002
Self-citationPyClone: statistical inference of clonal population structure in cancer
Roth, A., Khattra, J., Yap, D., Wan, A., Laks, E., Biele, J., Ha, G., Aparicio, S., Bouchard-Côté, A., & Shah, S. P. (2014) · Nature Methods · doi:10.1038/nmeth.2883 · Cited by 999
Self-citationDeOme, K. B., Faulkin, L. J., Bern, H. A., & Blair, P. B. (1959) · PubMed · Cited by 993
Pece, S., Tosoni, D., Confalonieri, S., Mazzarol, G., Vecchi, M., Ronzoni, S., Bernard, L., Viale, G., Pelicci, P. G., & Di Fiore, P. P. (2010) · Cell · doi:10.1016/j.cell.2009.12.007 · Cited by 947
Bertotti, A., Migliardi, G., Galimi, F., Sassi, F., Torti, D., Isella, C., Corà, D., Di Nicolantonio, F., Buscarino, M., Petti, C., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0109 · Cited by 939 · cited 1×
“One of the best examples has been seen in the case of colorectal cancer, where PDX studies showed that tumors with a mutated KRAS gene were not responsive to cetuximab [213], closely mimicking that seen in large clinical trials.”
Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P., Matrisian, L. M., Richmond, A., Lin, P. C., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.004 · Cited by 918 · cited 1×
“lineage may account for some of the advantages of this immunocompromised background [130].”
Hammond, M. E. H., Hayes, D. F., Dowsett, M., Allred, D. C., Hagerty, K. L., Badve, S., Fitzgibbons, P. L., Francis, G., Goldstein, N. S., Hayes, M., et al. (2010) · Archives of Pathology & Laboratory Medicine · doi:10.5858/134.6.907 · Cited by 895
Smyth, M. J., Dunn, G. P., & Schreiber, R. D. (2006) · Advances in Immunology · doi:10.1016/s0065-2776(06)90001-7 · Cited by 870
‘Nude’, a new hairless gene with pleiotropic effects in the mouse
Flanagan, S. P. (1966) · Genetical Research · doi:10.1017/s0016672300010168 · Cited by 869
Blunt, T., Finnie, N. J., Taccioli, G. E., Smith, G. C. M., Demengeot, J., Gottlieb, T. M., Mizuta, R., Varghese, A. J., Alt, F. W., Jeggo, P. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90360-7 · Cited by 864
Johnson, J. I., Decker, S., Zaharevitz, D., Rubinstein, L. V., Venditti, J. M., Schepartz, S., Kalyandrug, S., Christian, M., Arbuck, S., Hollingshead, M., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1796 · Cited by 856
Journal of the National Cancer Institute
(1969) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/43.6.1387 · Cited by 832
Reconstruction of functionally normal and malignant human breast tissues in mice
Kuperwasser, C., Chavarria, T., Wu, M., Magrane, G., Gray, J. W., Carey, L., Richardson, A., & Weinberg, R. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401064101 · Cited by 804
Burstein, H. J., Prestrud, A. A., Seidenfeld, J., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. E., Giordano, S. H., Hudis, C. A., Malin, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3756 · Cited by 796
Development and function of human innate immune cells in a humanized mouse model
Rongvaux, A., Willinger, T., Martinek, J., Strowig, T., Gearty, S. V., Teichmann, L. L., Saito, Y., Marches, F., Halene, S., Palucka, A. K., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2858 · Cited by 789
Burstein, H. J., Temin, S., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. E., Giordano, S. H., Hudis, C. A., Rowden, D., Solky, A. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.2258 · Cited by 786
Clonal Architecture of Secondary Acute Myeloid Leukemia
Walter, M. J., Shen, D., Ding, L., Shao, J., Koboldt, D. C., Chen, K., Larson, D. E., McLellan, M. D., Dooling, D., Abbott, R., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1106968 · Cited by 775
New member of the winged-helix protein family disrupted in mouse and rat nude mutations
Nehls, M., Pfeifer, D., Schorpp, M., Hedrich, H., & Boehm, T. (1994) · Nature · doi:10.1038/372103a0 · Cited by 644
Li, S., Shen, D., Shao, J., Crowder, R., Liu, W., Prat, A., He, X., Liu, S., Hoog, J., Lu, C., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.08.022 · Cited by 626
Self-citationBreast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks
Liu, S., Ginestier, C., Ou, S. J., Clouthier, S. G., Patel, S. H., Monville, F., Korkaya, H., Heath, A., Dutcher, J., Kleer, C. G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-0538 · Cited by 611
Self-citationDynamics of genomic clones in breast cancer patient xenografts at single-cell resolution
Eirew, P., Steif, A., Khattra, J., Ha, G., Yap, D., Farahani, H., Gelmon, K., Chia, S., Mar, C., Wan, A., et al. (2015) · Nature · doi:10.1038/nature13952 · Cited by 598
Self-citationNon-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity
Marusyk, A., Tabassum, D. P., Altrock, P. M., Almendro, V., Michor, F., & Polyak, K. (2014) · Nature · doi:10.1038/nature13556 · Cited by 597
Klopp, A. H., Gupta, A., Spaeth, E., Andreeff, M., & Marini, F. (2011) · Stem Cells · doi:10.1002/stem.559 · Cited by 562 · cited 1×
“These cells were shown to enhance mammosphere formation in vitro [187,188], and to stimulate growth and metastasis of established xenografts in vivo [71,189,190,175].”
Foti, M. E., Mennite, M. A., Pusztay, H. M., Michael, M., Barry, A., Musumeci, L. P., Tang, D., Pickels, M. A., Griffith, T. A., Barbacid, M., et al. (1992) · Cited by 562
Single-Cell Exome Sequencing and Monoclonal Evolution of a JAK2-Negative Myeloproliferative Neoplasm
Hou, Y., Song, L., Zhu, P., Zhang, B., Tao, Y., Xu, X., Li, F., Wu, K., Liang, J., Shao, D., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.028 · Cited by 541
Hammond, M. E. H., Hayes, D. F., Dowsett, M., et al. (2010) · PubMed Central · Cited by 541
Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
DeNardo, D. G., Andreu, P., & Coussens, L. M. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9223-6 · Cited by 515
Regulation of In Situ to Invasive Breast Carcinoma Transition
Hu, M., Yao, J., Carroll, D. K., Weremowicz, S., Chen, H., Carrasco, D., Richardson, A., Violette, S., Nikolskaya, T., Nikolsky, Y., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.03.007 · Cited by 502
Zhang, X., Claerhout, S., Prat, A., Dobrolecki, L. E., Petrovic, I., Lai, Q., Landis, M. D., Wiechmann, L., Schiff, R., Giuliano, M., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4081 · Cited by 481
Self-citationThe beige mutation in the mouse selectively impairs natural killer cell function
Roder, J., & Duwe, A. K. (1979) · Nature · doi:10.1038/278451a0 · Cited by 481
Gillet, J.-P., Calcagno, A. M., Varma, S., Marino, M., Green, L. J., Vora, M. I., Patel, C., Orina, J. N., Eliseeva, T. A., Singal, V., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111840108 · Cited by 477 · cited 2×
“Long-term culture has, in several cases, been associated with extensive clonal selection and loss of heterogeneity [94, 96].”
Postnatal mammary gland development requires macrophages and eosinophils
Gouon-Evans, V., Rothenberg, M. E., & Pollard, J. W. (2000) · Development · doi:10.1242/dev.127.11.2269 · Cited by 468
A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays
Marangoni, E., Vincent-Salomon, A., Auger, N., Degeorges, A., Assayag, F., de Cremoux, P., de Plater, L., Guyader, C., De Pinieux, G., Judde, J.-G., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0078 · Cited by 422
Self-citationEffect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
Osborne, C. K., Hobbs, K., & Clark, G. M. (1985) · PubMed · Cited by 402
Park, S. Y., Lee, H. E., Li, H., Shipitsin, M., Gelman, R., & Polyak, K. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1532 · Cited by 400
Genome-wide copy number analysis of single cells
Baslan, T., Kendall, J., Rodgers, L., Cox, H., Riggs, M., Stepansky, A., Troge, J., Ravi, K., Esposito, D., Lakshmi, B., et al. (2012) · Nature Protocols · doi:10.1038/nprot.2012.039 · Cited by 380
Ha, G., Roth, A., Khattra, J., Ho, J., Yap, D., Prentice, L. M., Melnyk, N., McPherson, A., Bashashati, A., Laks, E., et al. (2014) · Genome Research · doi:10.1101/gr.180281.114 · Cited by 371
Self-citationSubclonal phylogenetic structures in cancer revealed by ultra-deep sequencing
Campbell, P. J., Pleasance, E. D., Stephens, P. J., Dicks, E., Rance, R., Goodhead, I., Follows, G. A., Green, A. R., Futreal, P. A., & Stratton, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801523105 · Cited by 365
Mantovani, A., Sica, A., Allavena, P., Garlanda, C., & Locati, M. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.02.008 · Cited by 350
Eirew, P., Stingl, J., Raouf, A., Turashvili, G., Aparicio, S., Emerman, J. T., & Eaves, C. J. (2008) · Nature Medicine · doi:10.1038/nm.1791 · Cited by 339
Self-citationRakhra, K., Bachireddy, P., Zabuawala, T., Zeiser, R., Xu, L., Kopelman, A., Fan, A. C., Yang, Q., Braunstein, L., Crosby, E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.002 · Cited by 339
Evidence of functional lymphocytes in some (leaky) scid mice.
Bosma, G. C., Fried, M., Custer, R. P., Carroll, A. M., Gibson, D. M., & Bosma, M. J. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.3.1016 · Cited by 337
Weigelt, B., Lo, A. T., Park, C. C., Gray, J. W., & Bissell, M. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0502-2 · Cited by 334
Subtyping of triple‐negative breast cancer: Implications for therapy
Abramson, V. G., Lehmann, B. D., Ballinger, T. J., & Pietenpol, J. A. (2015) · Cancer · doi:10.1002/cncr.28914 · Cited by 333
Breast cancer intra-tumor heterogeneity
Martelotto, L. G., Ng, C. K., Piscuoglio, S., Weigelt, B., & Reis-Filho, J. S. (2014) · Breast Cancer Research · doi:10.1186/bcr3658 · Cited by 332
Self-citationMCF10AT: a model for the evolution of cancer from proliferative breast disease.
Dawson, P. J., Wolman, S. R., Tait, L. R., Heppner, G. H., & Miller, F. R. (1996) · Europe PMC (PubMed Central) · Cited by 314
Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor.
Rong, S., Bodescot, M., Blair, D., Dunn, J., Nakamura, T., Mizuno, K., Park, M., Chan, A., Aaronson, S., & Vande Woude, G. F. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5152 · Cited by 312
Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms.
Custer, R. P., Bosma, G. C., & Bosma, M. J. (1985) · PubMed · Cited by 310
RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers
Nolan, E., Vaillant, F., Branstetter, D., Pal, B., Giner, G., Whitehead, L., Lok, S. W., Mann, G. B., Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab), Rohrbach, K., et al. (2016) · Nature Medicine · doi:10.1038/nm.4118 · Cited by 309
Self-citationDistinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines
Hollestelle, A., Nagel, J. H. A., Smid, M., Lam, S., Elstrodt, F., Wasielewski, M., Ng, S. S., French, P. J., Peeters, J. K., Rozendaal, M. J., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0460-8 · Cited by 301
Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution
Allred, D. C., Wu, Y., Mao, S., Nagtegaal, I. D., Lee, S., Perou, C. M., Mohsin, S. K., O'Connell, P., Tsimelzon, A., & Medina, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1127 · Cited by 285
Comparison of human cord blood engraftment between immunocompromised mouse strains
McDermott, S. P., Eppert, K., Lechman, E. R., Doedens, M., & Dick, J. E. (2010) · Blood · doi:10.1182/blood-2010-02-271841 · Cited by 284
Patient-derived xenograft models of breast cancer and their predictive power
Whittle, J. R., Lewis, M. T., Lindeman, G. J., & Visvader, J. E. (2015) · Breast Cancer Research · doi:10.1186/s13058-015-0523-1 · Cited by 282
Self-citationTargeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer
Hughes, P. E., Caenepeel, S., & Wu, L. C. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.04.010 · Cited by 282
Targeting BCL-2 with the BH3 Mimetic ABT-199 in Estrogen Receptor-Positive Breast Cancer
Vaillant, F., Merino, D., Lee, L., Breslin, K., Pal, B., Ritchie, M. E., Smyth, G. K., Christie, M., Phillipson, L. J., Burns, C. J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.002 · Cited by 276
Self-citationAn intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
Behbod, F., Kittrell, F. S., LaMarca, H., Edwards, D., Kerbawy, S., Heestand, J. C., Young, E., Mukhopadhyay, P., Yeh, H.-W., Allred, D. C., et al. (2009) · Breast Cancer Research · doi:10.1186/bcr2358 · Cited by 268
Self-citationAnticancer drug development: the grand challenges
Hait, W. N. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3144 · Cited by 230
DeRose, Y. S., Gligorich, K. M., Wang, G., Georgelas, A., Bowman, P., Courdy, S. J., Welm, A. L., & Welm, B. E. (2013) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph1423s60 · Cited by 226
Self-citationMolecular cytogenetic analysis of 11 new breast cancer cell lines
Forozan, F., Veldman, R., Ammerman, C. A., Parsa, N. Z., Kallioniemi, A., Kallioniemi, O.-P., & Ethier, S. P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6695007 · Cited by 219
Cashman, J. D., Lapidot, T., Wang, J. C. Y., Doedens, M., Shultz, L. D., Lansdorp, P., Dick, J. E., & Eaves, C. J. (1997) · Blood · doi:10.1182/blood.v89.12.4307 · Cited by 218
Gouon-Evans, V., Lin, E. Y., & Pollard, J. W. (2002) · Breast Cancer Research · doi:10.1186/bcr441 · Cited by 217
Sflomos, G., Dormoy, V., Metsalu, T., Jeitziner, R., Battista, L., Scabia, V., Raffoul, W., Delaloye, J.-F., Treboux, A., Fiche, M., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.02.002 · Cited by 217
Self-citationSanmamed, M. F., Chester, C., Melero, I., & Kohrt, H. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw041 · Cited by 207
Xenograft Model of Progressive Human Proliferative Breast Disease
Miller, F. R., Soule, H. D., Tait, L., Pauley, R. J., Wolman, S. R., Dawson, P. J., & Heppner, G. H. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.21.1725 · Cited by 206
Sensitization of BCL-2–expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737
Oakes, S. R., Vaillant, F., Lim, E., Lee, L., Breslin, K., Feleppa, F., Deb, S., Ritchie, M. E., Takano, E., Ward, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104778108 · Cited by 193
Self-citationRamakrishna, N., Temin, S., Chandarlapaty, S., Crews, J. R., Davidson, N. E., Esteva, F. J., Giordano, S. H., Gonzalez-Angulo, A. M., Kirshner, J. J., Krop, I., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.0955 · Cited by 191
Angiogenesis as a marker of preneoplastic lesions of the human breast
Brem, S. S., Jensen, H. M., & Gullino, P. M. (1978) · Cancer · doi:10.1002/1097-0142(197801)41:1<239::aid-cncr2820410133>3.0.co;2-x · Cited by 189
Pflumio, F., Izac, B., Katz, A., Shultz, L., Vainchenker, W., & Coulombel, L. (1996) · Blood · doi:10.1182/blood.v88.10.3731.bloodjournal88103731 · Cited by 187
Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice
Soule, H. D., & McGrath, C. M. (1980) · Cancer Letters · doi:10.1016/0304-3835(80)90042-7 · Cited by 178
Systemic Stromal Effects of Estrogen Promote the Growth of Estrogen Receptor–Negative Cancers
Gupta, P. B., Proia, D., Cingoz, O., Weremowicz, J., Naber, S. P., Weinberg, R. A., & Kuperwasser, C. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3895 · Cited by 175
Klopp, A. H., Lacerda, L., Gupta, A., Debeb, B. G., Solley, T., Li, L., Spaeth, E., Xu, W., Zhang, X., Lewis, M. T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012180 · Cited by 173
Self-citationYi, B., Williams, P. J., Niewolna, M., Wang, Y., & Yoneda, T. (2002) · PubMed · Cited by 172
Intratumor Heterogeneity in Breast Cancer
de Beça, F. F., & Polyák, K. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22909-6_7 · Cited by 169
Regulation of Growth and Spacing of Gland Elements in the Mammary Fat Pad of the C3H Mouse 2
(1960) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/24.4.953 · Cited by 165
De Luca, F., Rotunno, G., Salvianti, F., Galardi, F., Pestrin, M., Gabellini, S., Simi, L., Mancini, I., Vannucchi, A. M., Pazzagli, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8431 · Cited by 159
Overcoming Current Limitations in Humanized Mouse Research
Brehm, M. A., Shultz, L. D., Luban, J., & Greiner, D. L. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit319 · Cited by 154
ABNORMAL DEVELOPMENT OF THE THYMUS IN "NUDE" MICE
Wortis, H. H., Nehlsen, S., & Owen, J. J. T. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.134.3.681 · Cited by 153
Sikora, M. J., Cooper, K. L., Bahreini, A., Luthra, S., Wang, G., Chandran, U. R., Davidson, N. E., Dabbs, D. J., Welm, A. L., & Oesterreich, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2779 · Cited by 146
Self-citationHampton, O. A., den Hollander, P., Miller, C. A., Delgado, D. A., Li, J., Coarfa, C., Harris, R. A., Richards, S., Scherer, S. E., Muzny, D. M., et al. (2008) · Genome Research · doi:10.1101/gr.080259.108 · Cited by 145
Reconstruction of human mammary tissues in a mouse model
Proia, D. A., & Kuperwasser, C. (2006) · Nature Protocols · doi:10.1038/nprot.2006.31 · Cited by 144
Kabos, P., Finlay-Schultz, J., Li, C., Kline, E. C., Finlayson, C. A., Wisell, J. A., Manuel, C. A., Edgerton, S. M., Harrell, J. C., ELIAS, A. D., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2164-8 · Cited by 139
Self-citationIs the future of personalized therapy in triple-negative breast cancer based on molecular subtype?
Du, F. L., Eckhardt, B. L., Lim, B., Litton, J. K., Moulder, S. L., Meric‐Bernstam, F., Gonzalez-Angulo, A. M., & Ueno, N. T. (2015) · Oncotarget · doi:10.18632/oncotarget.3849 · Cited by 137
Self-citationCD4 regulatory T cells in human cancer pathogenesis
Knutson, K. L., Disis, M. L., & Salazar, L. G. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0194-y · Cited by 132
Charafe‐Jauffret, E., Ginestier, C., Bertucci, F., Cabaud, O., Wicinski, J., Finetti, P., Josselin, E., Adélaïde, J., Nguyen, T.-T., Monville, F., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4704 · Cited by 131
Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice.
Seibert, K., Shafie, S. M., Triche, T. J., Whang‐Peng, J., O’Brien, S. J., TONEY, J. H., Huff, K. K., & Lippman, M. E. (1983) · PubMed · Cited by 127
Stromal Estrogen Receptor-α Promotes Tumor Growth by Normalizing an Increased Angiogenesis
Péqueux, C., Raymond‐Letron, I., Blacher, S., Boudou, F., Adlanmérini, M., Fouque, M.-J., Rochaix, P., Noël, A., Foidart, J.-M., Krust, A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3768 · Cited by 127
Clarke, R. C. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01806079 · Cited by 126
Self-citationAML cells are differentially sensitive to chemotherapy treatment in a human xenograft model
Wunderlich, M., Mizukawa, B. E., Chou, F., Sexton, C., Shrestha, M., Saunthararajah, Y., & Mulloy, J. C. (2013) · Blood · doi:10.1182/blood-2012-10-464677 · Cited by 124
Holzapfel, B. M., Wagner, F., Thibaudeau, L., Lévesque, J.-P., & Hutmacher, D. W. (2015) · Stem Cells · doi:10.1002/stem.1978 · Cited by 117
Pereira, B., Chin, S., Rueda, O. M., Vollan, H. K. M., Provenzano, E., Bardwell, H. A., Pugh, M., Jones, L. R., Russell, R., Sammut, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms11908 · Cited by 115
Self-citationThe Cancer Journal From Scientific American
Prelec, A. (1996) · JAMA · doi:10.1001/jama.1996.03540170090047 · Cited by 114
Wege, A. K., Ernst, W., Eckl, J., Frankenberger, B., Vollmann‐Zwerenz, A., Männel, D. N., Ortmann, O., Kroemer, A., & Brockhoff, G. (2011) · International Journal of Cancer · doi:10.1002/ijc.26159 · Cited by 112
A Majority of Low (1-10%) ER Positive Breast Cancers Behave Like Hormone Receptor Negative Tumors
Prabhu, J. S., Korlimarla, A., Desai, K., Alexander, A., Raghavan, R., Anupama, C. E., Dendukuri, N., Manjunath, S., Correa, M., Raman, N., et al. (2014) · Journal of Cancer · doi:10.7150/jca.7668 · Cited by 111
Finding the tumor copycat: Therapy fails, patients don’t
Ellis, L. M., & Fidler, I. J. (2010) · Nature Medicine · doi:10.1038/nm0910-974 · Cited by 109
Zhou, Q., Facciponte, J. G., Jin, M., Shen, Q., & Lin, Q. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.10.015 · Cited by 109
Single-cell mutational profiling and clonal phylogeny in cancer
Potter, N. E., Ermini, L., Papaemmanuil, E., Cazzaniga, G., Vijayaraghavan, G., Titley, I., Ford, A., Campbell, P., Kearney, L., & Greaves, M. (2013) · Genome Research · doi:10.1101/gr.159913.113 · Cited by 107
Strain-dependent leakiness of mice with severe combined immune deficiency
Nonoyama, S., Smith, F. O., Bernstein, I. D., & Ochs, H. D. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.9.3817 · Cited by 107
Modeling of response to endocrine therapy in a panel of human luminal breast cancer xenografts
Cottu, P. H., Marangoni, E., Assayag, F., de Crémoux, P., Vincent‐Salomon, A., Guyader, C., de Plater, L., Ganem‐Elbaz, C., Karboul, N., Fontaine, J. J., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1815-5 · Cited by 105
Self-citationBrain Metastases of Breast Cancer
Palmieri, D., Smith, Q. R., Lockman, P. R., Bronder, J. L., Gril, B., Chambers, A. F., Weil, R. J., & Steeg, P. S. (2007) · Breast Disease · doi:10.3233/bd-2007-26112 · Cited by 104
Hudson, W., Li, Q., Le, C., & Kersey, J. (1998) · Leukemia · doi:10.1038/sj.leu.2401236 · Cited by 103
Nugoli, M., Chuchana, P., Vendrell, J. A., Orsetti, B., Ursule, L., Nguyen, C., Birnbaum, D., Douzery, E., Cohen, P. A., & Theillet, C. G. (2003) · BMC Cancer · doi:10.1186/1471-2407-3-13 · Cited by 101
Patient-Derived Tumor Xenografts Are Susceptible to Formation of Human Lymphocytic Tumors
Bondarenko, G. I., Ugolkov, A. V., Rohan, S. M., Kulesza, P., Dubrovskyi, O., Gursel, D. B., Mathews, J. A., O’Halloran, T. V., Wei, J., & Mazar, A. P. (2015) · Neoplasia · doi:10.1016/j.neo.2015.09.004 · Cited by 97
Christianson, S. W., Greiner, D. L., Schweitzer, I. B., et al. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0193 · Cited by 90
Contributions of estrogen to ER-negative breast tumor growth
Gupta, P. B., & Kuperwasser, C. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.025 · Cited by 86
The Omics of Triple-Negative Breast Cancers
Xu, H., Eirew, P. D., Mullaly, S. C., & Aparicio, S. A. J. R. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2013.207167 · Cited by 84
Self-citationValidity of mouse mammary tumour models for human breast cancer: Comparative pathology
Cardiff, R. D. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010115)52:2<224::aid-jemt1007>3.0.co;2-a · Cited by 84
Zhang, H., Cohen, A. L., Krishnakumar, S., Wapnir, I., Veeriah, S., Deng, G. Y., Coram, M., Piskun, C. M., Longacre, T. A., Herrler, M., et al. (2014) · Breast Cancer Research · doi:10.1186/bcr3640 · Cited by 78
Models of breast cancer: is merging human and animal models the future?
Kim, J. B., O’Hare, M. J., & Stein, R. C. (2003) · Breast Cancer Research · doi:10.1186/bcr645 · Cited by 74
McAuliffe, P. F., Evans, K. W., Akçakanat, A., Chen, K., Zheng, X., Zhao, H., Eterovic, A. K., Sangai, T., Holder, A. M., Sharma, C., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136851 · Cited by 71
Self-citationdu Manoir, S., Orsetti, B., Bras-Gonçalves, R., Nguyen, T.-T., Lasorsa, L., Boissière‐Michot, F., Massemin, B., Colombo, P., Bibeau, F., Jacot, W., et al. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.11.010 · Cited by 69
Utama, F. E., LeBaron, M. J., Neilson, L. M., Sultan, A., Parlow, A. F., Wagner, K.-U., & Rui, H. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06560 · Cited by 64
Natural killer cells in breast cancer cell growth and metastasis in SCID mice
Dewan, M. Z., Terunuma, H., Ahmed, S., Ohba, K., Takada, M., Tanaka, Y., Toi, M., & Yamamoto, N. (2005) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(05)80082-4 · Cited by 61
Kaur, H., Mao, S., Shah, S. K., Gorski, D. H., Krawetz, S. A., Sloane, B. F., & Mattingly, R. R. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.13.4 · Cited by 61
Iyer, V., Klebba, I., McCready, J., Arendt, L. M., Betancur-Boissel, M., Wu, M.-F., Zhang, X., Lewis, M. T., & Kuperwasser, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3287 · Cited by 60
Self-citationMoon, H., Oh, K., Lee, J., Lee, M., Kim, J.-Y., Yoo, T.-K. R., Seo, M. W., Park, A. K., Ryu, H. S., Jung, E., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3585-y · Cited by 59
Giuliano, M., Herrera, S., Christiny, P., Shaw, C. A., Creighton, C. J., Mitchell, T., Bhat, R. R., Zhang, X., Mao, S., Dobrolecki, L. E., et al. (2015) · Breast Cancer Research · doi:10.1186/s13058-014-0508-5 · Cited by 58
Self-citationEyre, R., Alférez, D., Spence, K., Kamal, M. A., Shaw, F. L., Simões, B. M., Santiago-Gómez, A., Sarmiento-Castro, A., Bramley, M., Absar, M. S., et al. (2016) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-016-9361-8 · Cited by 58
Self-citationHumanized mice: Current states and perspectives
Garcia, S., & Freitas, A. A. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.03.009 · Cited by 53
Powell, E., Shao, J., Yuan, Y., Chen, H.-C., Cai, S., Echeverria, G. V., Mistry, N. A., Decker, K. F., Schlosberg, C., Do, K.-A., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0673-9 · Cited by 52
Self-citationCheckpoint Inhibitors and Their Application in Breast Cancer
Bedognetti, D., Maccalli, C., Bader, S. B. J. A., Marincola, F. M., & Seliger, B. (2016) · Breast Care · doi:10.1159/000445335 · Cited by 51
Efficient engraftment of human primary breast cancer transplants in nonconditioned NOD/Scid mice
Beckhove, P., Schütz, F., Diel, I., Solomayer, E., Bastert, G., Förster, J., Feuerer, M., Bai, L., Sinn, H., Umansky, V., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11125 · Cited by 50
Petrillo, L. A., Wolf, D. M., Kapoun, A. M., Wang, N. J., Barczak, A. J., Xiao, Y., Körkaya, H., Baehner, F. L., Lewicki, J. A., Wicha, M. S., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2226-y · Cited by 47
Self-citationEstablishment of Patient‐Derived Xenograft (PDX) Models of Human Breast Cancer
Zhang, X., & Lewis, M. T. (2013) · Current Protocols in Mouse Biology · doi:10.1002/9780470942390.mo120140 · Cited by 45
Self-citationGrowth and metastasis of surgical specimens of human breast carcinomas in SCID mice.
Sakakibara, T., Xu, Y., Bumpers, H. L., Chen, F. A., Bankert, R. B., Arredondo, M. A., Edge, S. B., & Repasky, E. A. (1996) · PubMed · Cited by 42
Hatem, R., Botty, R. E., Château‐Joubert, S., Servely, J., Labiod, D., de Plater, L., Assayag, F., Coussy, F., Callens, C., Vacher, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10195 · Cited by 41
Self-citationTherapeutic Breast Cancer Vaccines
Shumway, N. M., Ibrahim, N. K., Ponniah, S., Peoples, G. E., & Murray, J. L. (2009) · BioDrugs · doi:10.2165/11313490-000000000-00000 · Cited by 34
Lum, D. H., Matsen, C. B., Welm, A. L., & Welm, B. E. (2012) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph1422s59 · Cited by 32
Self-citationInnate immune response to human bone marrow fibroblastic cell implantation in CB17 scid/beige mice
Xia, Z., Taylor, P. R., Locklin, R. M., Gordon, S., Cui, Z., & Triffitt, J. T. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20730 · Cited by 27
Growth and metastasis of human breast cancers in athymic nude mice
Murthy, M. S., Scanlon, E. F., Jelachich, M. L., Klipstein, S., & Goldschmidt, R. A. (1995) · Clinical & Experimental Metastasis · doi:10.1007/bf00144013 · Cited by 26
Considerations on the preneoplastic lesions of the mammary gland.
Pm, G. (1977) · PubMed Central · Cited by 14
Studying Drug Resistance Using Genetically Engineered Mouse Models for Breast Cancer
Rottenberg, S., Pajic, M., & Jonkers, J. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-416-6_3 · Cited by 12
Cited by
MULTI-seq: sample multiplexing for single-cell RNA sequencing using lipid-tagged indices
McGinnis, C. S., Patterson, D. M., Winkler, J., Conrad, D. N., Hein, M. Y., Srivastava, V., Hu, J. L., Murrow, L. M., Weissman, J. S., Werb, Z., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0433-8 · Cited by 643
Cazet, A. S., Hui, M. N., Elsworth, B. L., Wu, S. Z., Roden, D., Chan, C.-L., Skhinas, J. N., Collot, R., Yang, J., Harvey, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05220-6 · Cited by 437
Guillen, K. P., Fujita, M., Butterfield, A. J., Scherer, S. D., Bailey, M. H., Chu, Z., DeRose, Y. S., Zhao, L., Cortes-Sanchez, E., Yang, C.-H., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00337-6 · Cited by 416
Self-citationPatient-derived xenograft (PDX) models, applications and challenges in cancer research
Abdolahi, S., Ghazvinian, Z., Muhammadnejad, S., Saleh, M., Asadzadeh Aghdaei, H., & Baghaei, K. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03405-8 · Cited by 326
Echeverria, G. V., Ge, Z., Seth, S., Zhang, X., Jeter-Jones, S., Zhou, X., Cai, S., Tu, Y., McCoy, A., Peoples, M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aav0936 · Cited by 306
Self-citation
Metadata
- Authors
- Dobrolecki, L. E., Airhart, S. D., Alferez, D. G., Aparicio, S., Behbod, F., Bentires-Alj, M., Brisken, C., Bult, C. J., Cai, S., Clarke, R. B., Dowst, H., Ellis, M. J., Gonzalez-Suarez, E., Iggo, R. D., Kabos, P., Li, S., Lindeman, G. J., Marangoni, E., McCoy, A., Meric-Bernstam, F., Piwnica-Worms, H., Poupon, M.-F., Reis-Filho, J., Sartorius, C. A., Scabia, V., Sflomos, G., Tu, Y., Vaillant, F., Visvader, J. E., Welm, A., Wicha, M. S., & Lewis, M. T.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2016-12
- Volume
- 35
- Issue
- 4
- Pages
- 547-573
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W2564066883
- Cited by
- 267
- References
- 193
- FWCI
- 1.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.